What is Topiramate?

  • Author:Hubei Ocean Biotech Co,.LTd
  • Release on :2016-06-20
Topiramate (brand name Topamax) is an anticonvulsant(antiepilepsy) drug. In late 2012, topiramate was approved by theUnited States Food and Drug Administration (FDA) in combination with phentermine for weight loss. The drug had previously been used off-label for this purpose. Topiramate was originally produced by Ortho-McNeil Neurologics and Noramco, Inc., both divisions of the Johnson & Johnson Corporation. This medication was discovered in 1979 by Bruce E. Maryanoff and Joseph F. Gardocki during their research work at McNeil Pharmaceutical.

Topiramate came into commercial use in 1996. Generic versions are available in Canada and these were approved by the FDA in September 2006. Mylan Pharmaceuticals was recently granted final approval for generic topiramate by the FDA for sale in the United States.
 The last patent for topiramate in the U.S. was for use in children and expired on February 28, 2009.

Hubei Ocean Biotech Co., Ltd, China pharmaceutical products and APIs supplier, with credible service and the honest management, we have gained good reputation at domestic and abroad market. The main cause is not only for our honesty and service, but more importantly for our quality insurance about the products we offer. That's why customers choose us, our products are rest assured to buy, it is our honesty and service solved customer’s worries. That’s why we could be able to extend our market and serve more people.